Local delivery methods of therapeutic agents in the treatment of diffuse intrinsic brainstem gliomas

Area of Science:

• Pediatric neuro-oncology
• Central nervous system (CNS) tumors
• Brainstem glioma research

Background:

• Diffuse intrinsic pontine gliomas (DIPGs) represent the most common type of pediatric brainstem glioma.
• DIPGs are characterized by rapid progression and a median survival of less than 12 months.
• Current standard treatments, including radiation, have limited long-term efficacy, and systemic therapies have yielded disappointing results.

Purpose of the Study:

• To provide an updated review of current preclinical and clinical research on treatment strategies for brainstem gliomas.
• To highlight recent advancements in therapeutic agents and drug delivery methods for DIPGs.
• To consolidate current knowledge on investigational treatment options for pediatric brainstem gliomas.

Main Methods:

• Review of recent preclinical studies investigating novel therapeutic agents.
• Analysis of ongoing and completed clinical trials for brainstem gliomas.
• Examination of research focusing on localized and targeted drug delivery systems.

Main Results:

• Disappointing outcomes from clinical trials using systemic administration of various therapeutic agents.
• Emerging focus on improving chemotherapeutic agents for DIPG treatment.
• Exploration of innovative localized and targeted drug delivery methods.

Conclusions:

• There is a critical need for more effective treatments for diffuse intrinsic pontine gliomas.
• Advancements in chemotherapy and drug delivery show promise for improving outcomes.
• Continued research in preclinical and clinical settings is essential for developing novel therapeutic strategies.